Solutions

Solutions

Explore end-to-end solutions throughout development — from portfolio optimization and regulatory strategy, to Phase I-IV clinical trials, market access planning, and more.

See solutions

WHAT WE DO

HOW WE DO IT

Overview

Portfolio management and asset valuation
- Building patient insights into assets, profile and claims
- Portfolio optimization
- Asset valuation and indication prioritization
- Early evidence review
- Integrated development strategy and planning
Early development and innovation
- Early Phase Clinical Trials
- Site Alliance Network and KOL Engagement
- Quantitative Clinical Pharmacology and Model-Informed Drug Development (MIDD)
- Regulatory Strategy
- Real World Evidence
- Market Access Consulting, Strategy, and Delivery
- Dedicated early phase clinical units
- Biomarker and Genomic Medicine Strategy
- Integrated evidence generation planning
- Clinical Logistics
- Medical Communications
Integrated clinical development
- Phase IIB-IV Clinical Trial Solutions
- Real World Evidence
- Quantitative Clinical Pharmacology and Model-Informed Drug Development (MIDD)
- Protocol-Driven, Customized Site Solution Strategy
- Patient Inclusion
- Regulatory Strategy, Submissions, Compliance, and Outsourcing
- Market Access Strategy and Delivery
- Clinical Logistics
- Clinical Development Technology Optimization
- Integrated evidence generation planning
- Medical Communications
- Drug Safety and Pharmacovigilance
Approval and access
- Global Regulatory Submissions and Outsourcing
- Real World Evidence
- Compliance and Risk Management
- Market Access Strategy and Delivery
- Integrated evidence generation planning
- Medical Communications
- Drug Safety and Pharmacovigilance
- Health economics modelling and simulation
Value substantiation lifecycle management
- Real-World Evidence, Market Access Strategy and Planning
- Regulatory Compliance
- Lifecycle Optimization
- Integrated evidence generation planning
- Medical Communications
FSP Integrated Solutions
- Gain an advantage through FSP
Operational excellence
Medical affairs for clinical trials
Clinical study start up
ParexelAI
- Parexel and Paradigm
- Leveraging AI in clinical development

Flexible, scalable solutions.

FSP Integrated Solutions

Our FSP solutions combine talent, expertise, technology, and global scale to help sponsors increase productivity, respond to changing pipeline demands, and bring therapies to patients faster.

Learn more

Biotech
Therapeutic Expertise

Therapeutic Expertise

Utilize our expertise across therapeutic areas, combining innovative trial designs, leading clinical and regulatory expertise, global reach, and a passion for changing patient lives.

See expertise

THERAPEUTIC EXPERTISE

CROSS-THERAPEUTIC EXPERTISE

Overview

Cell and gene therapy
General medicine
- Gastroenterology CRO
- Respiratory CRO
- Endocrine & Metabolic CRO
- Cardiovascular CRO
- Women's health CRO
Infectious disease and vaccines
- Critical Care
- Hepatitis B
- Novel treatments in infectious disease
- Vaccines
Immunology
- Dermatology CRO
- Allergy CRO
Oncology CRO
- Bladder cancer CRO
- Breast cancer CRO
- Colorectal cancer CRO
- Gynecologic cancer CRO
- Head and neck cancer CRO
- Liver cancer CRO
- Lung cancer CRO
- Pancreatic cancer CRO
- Phase I oncology CRO
- Prostate cancer CRO
Neuroscience
- Neurology
- Psychiatry
Pediatrics
Rare Diseases
Hematology
- Non-malignant hematology
- Malignant hematology CRO
Ophthalmology CRO

RELATED INSIGHTS

The evidence gap in hematology: From trial endpoints to patient outcomes

Learn more

Rethinking strategies for rescue treatment in wet AMD and retinal vascular disease clinical trials

Learn more

Insights

Insights

Our experts help you stay at the forefront of the industry — and ahead of change.

Learn more

FEATURED INSIGHTS

NEW MEDICINES, NOVEL INSIGHTS

PODCAST

Clinical Trialblazers

Step into the world of biotech leaders and hear the untold stories behind their journeys to bring breakthrough innovations to life.

Listen Now

Cell & Gene Unscripted

Honest conversations with the experts shaping what's next

Watch the series

Participate

Participate

Thinking about joining a clinical trial? Learn the drug development process, what it’s like to participate, how to find a trial, and answers to frequently asked questions.

Learn more

INTERESTED IN PARTICIPATING?

TRIAL SITES

Overview

Patient volunteers
- Advisory Council
Healthy volunteers
Patient advocacy groups
Patient stories

HEAR FROM REAL PATIENTS

Patient Stories

Clinical study participation represents a deeply personal decision with potentially far-reaching impact, as evidenced by these inspiring individual stories that highlight both the life-changing potential for participants and the broader advancement of healthcare for all.

Learn more

Sites
About

About

We are one of the largest CROs in the world, speeding life-changing medicine to market by engaging patients With Heart™. Learn about who we are, what we do, and what we believe.

About Parexel

Overview

Leadership team
- Board of Directors
Global reach
Our Inclusion Strategy
Our sustainability strategy
Compliance, tax & privacy
- Compliance & Ethics
- Tax Strategy
- Privacy Policy
- Cookies and other web tracking
- Supplier Data Privacy Requirements
- Terms of Use
- French Gender Pay Data
- UK Gender Pay Data
- UK Modern Slavery Act Statement
- Ireland Gender Pay Data
- Supplier Inclusion Policy
- Vulnerability Reporting Program
Meet us at an event
- Poster presentations at EHA 2026
- Parexel Biotech Incubator

Main Menu

Solutions

Explore end-to-end solutions throughout development — from portfolio optimization and regulatory strategy, to Phase I-IV clinical trials, market access planning, and more.

See solutions

WHAT WE DO

HOW WE DO IT

Overview

Portfolio management and asset valuation
- Building patient insights into assets, profile and claims
- Portfolio optimization
- Asset valuation and indication prioritization
- Early evidence review
- Integrated development strategy and planning
Early development and innovation
- Early Phase Clinical Trials
- Site Alliance Network and KOL Engagement
- Quantitative Clinical Pharmacology and Model-Informed Drug Development (MIDD)
- Regulatory Strategy
- Real World Evidence
- Market Access Consulting, Strategy, and Delivery
- Dedicated early phase clinical units
- Biomarker and Genomic Medicine Strategy
- Integrated evidence generation planning
- Clinical Logistics
- Medical Communications
Integrated clinical development
- Phase IIB-IV Clinical Trial Solutions
- Real World Evidence
- Quantitative Clinical Pharmacology and Model-Informed Drug Development (MIDD)
- Protocol-Driven, Customized Site Solution Strategy
- Patient Inclusion
- Regulatory Strategy, Submissions, Compliance, and Outsourcing
- Market Access Strategy and Delivery
- Clinical Logistics
- Clinical Development Technology Optimization
- Integrated evidence generation planning
- Medical Communications
- Drug Safety and Pharmacovigilance
Approval and access
- Global Regulatory Submissions and Outsourcing
- Real World Evidence
- Compliance and Risk Management
- Market Access Strategy and Delivery
- Integrated evidence generation planning
- Medical Communications
- Drug Safety and Pharmacovigilance
- Health economics modelling and simulation
Value substantiation lifecycle management
- Real-World Evidence, Market Access Strategy and Planning
- Regulatory Compliance
- Lifecycle Optimization
- Integrated evidence generation planning
- Medical Communications
FSP Integrated Solutions
- Gain an advantage through FSP
Operational excellence
Medical affairs for clinical trials
Clinical study start up
ParexelAI
- Parexel and Paradigm
- Leveraging AI in clinical development

Flexible, scalable solutions.

FSP Integrated Solutions

Our FSP solutions combine talent, expertise, technology, and global scale to help sponsors increase productivity, respond to changing pipeline demands, and bring therapies to patients faster.

Learn more

Therapeutic Expertise

Utilize our expertise across therapeutic areas, combining innovative trial designs, leading clinical and regulatory expertise, global reach, and a passion for changing patient lives.

See expertise

THERAPEUTIC EXPERTISE

CROSS-THERAPEUTIC EXPERTISE

Overview

Cell and gene therapy
General medicine
- Gastroenterology CRO
- Respiratory CRO
- Endocrine & Metabolic CRO
- Cardiovascular CRO
- Women's health CRO
Infectious disease and vaccines
- Critical Care
- Hepatitis B
- Novel treatments in infectious disease
- Vaccines
Immunology
- Dermatology CRO
- Allergy CRO
Oncology CRO
- Bladder cancer CRO
- Breast cancer CRO
- Colorectal cancer CRO
- Gynecologic cancer CRO
- Head and neck cancer CRO
- Liver cancer CRO
- Lung cancer CRO
- Pancreatic cancer CRO
- Phase I oncology CRO
- Prostate cancer CRO
Neuroscience
- Neurology
- Psychiatry
Pediatrics
Rare Diseases
Hematology
- Non-malignant hematology
- Malignant hematology CRO
Ophthalmology CRO

RELATED INSIGHTS

The evidence gap in hematology: From trial endpoints to patient outcomes

Learn more

Rethinking strategies for rescue treatment in wet AMD and retinal vascular disease clinical trials

Learn more

Insights

Our experts help you stay at the forefront of the industry — and ahead of change.

Learn more

FEATURED INSIGHTS

NEW MEDICINES, NOVEL INSIGHTS

PODCAST

Clinical Trialblazers

Step into the world of biotech leaders and hear the untold stories behind their journeys to bring breakthrough innovations to life.

Listen Now

Cell & Gene Unscripted

Honest conversations with the experts shaping what's next

Watch the series

Participate

Thinking about joining a clinical trial? Learn the drug development process, what it’s like to participate, how to find a trial, and answers to frequently asked questions.

Learn more

INTERESTED IN PARTICIPATING?

TRIAL SITES

Overview

Patient volunteers
- Advisory Council
Healthy volunteers
Patient advocacy groups
Patient stories

HEAR FROM REAL PATIENTS

Patient Stories

Learn more

About

We are one of the largest CROs in the world, speeding life-changing medicine to market by engaging patients With Heart™. Learn about who we are, what we do, and what we believe.

About Parexel

Overview

Leadership team
- Board of Directors
Global reach
Our Inclusion Strategy
Our sustainability strategy
Compliance, tax & privacy
- Compliance & Ethics
- Tax Strategy
- Privacy Policy
- Cookies and other web tracking
- Supplier Data Privacy Requirements
- Terms of Use
- French Gender Pay Data
- UK Gender Pay Data
- UK Modern Slavery Act Statement
- Ireland Gender Pay Data
- Supplier Inclusion Policy
- Vulnerability Reporting Program
Meet us at an event
- Poster presentations at EHA 2026
- Parexel Biotech Incubator

From breakthrough science to real world impact — advancing cell and gene therapy, together

1 min

Published on: May 27, 2026

What if cell and gene therapy could reach more patients — without sending them farther from home? Advanced therapies are evolving. Access should, too.

In this on-demand ASGCT symposium, Parexel and industry leaders explore how community-based models, outpatient delivery, and patient-centered approaches can help expand access, reduce burden, and support the future of cell and gene therapy delivery.

Watch the video to hear how leaders across the industry are rethinking cell and gene therapy delivery — and what it will take to bring advanced therapies closer to patients.

What you’ll learn

Why traditional site models still limit access
How outpatient dosing is expanding what’s possible
What community-based care could unlock for patients and sponsors
What it takes to scale responsibly
How sponsors can rethink site strategy to expand access
Why trust, readiness, and partnerships matter

Return to Insights Center

Related Insights

Blog

The next generation of FSP will be defined by results, not headcount

Oct 8, 2026

CTB Podcast

Leading Neuroscience Innovation: A Biotech CEO Playbook with Neil Warma

Oct 5, 2026

Webinar

The evidence gap in hematology: From trial endpoints to patient outcomes

Oct 1, 2026

CTB Blog

EMA’s new pre-submission interactions model pilot: A fundamental shift toward submission readiness and predictable reviews

Sep 30, 2026

Blog

Rethinking strategies for rescue treatment in wet AMD and retinal vascular disease clinical trials

Sep 22, 2026

Blog

Cell & Gene Unscripted: Real-world evidence

Sep 16, 2026

Blog

Cell & Gene Unscripted: Rare and genetic diseases

Sep 16, 2026

Blog

Cell & Gene Unscripted: Rethinking clinical research

Sep 16, 2026

CTB Blog

Engage early, design once: turning early-phase trials into a program strategy

Sep 10, 2026

Blog

Greater empathy, greater efficiency: How patient-first clinical development benefits all of us

Sep 10, 2026

Blog

The future of patient recruitment: Building a more connected ecosystem

Sep 9, 2026

Case Study

Speed meets strategy: Delivering a critical FDA 1572 package in just seven days

Sep 9, 2026

Related Insights

Blog

The next generation of FSP will be defined by results, not headcount

Oct 8, 2026

CTB Podcast

Leading Neuroscience Innovation: A Biotech CEO Playbook with Neil Warma

Oct 5, 2026

Webinar

The evidence gap in hematology: From trial endpoints to patient outcomes

Oct 1, 2026

CTB Blog

EMA’s new pre-submission interactions model pilot: A fundamental shift toward submission readiness and predictable reviews

Sep 30, 2026

Blog

Rethinking strategies for rescue treatment in wet AMD and retinal vascular disease clinical trials

Sep 22, 2026

Blog

Cell & Gene Unscripted: Real-world evidence

Sep 16, 2026

Blog

Cell & Gene Unscripted: Rare and genetic diseases

Sep 16, 2026

Blog

Cell & Gene Unscripted: Rethinking clinical research

Sep 16, 2026

CTB Blog

Engage early, design once: turning early-phase trials into a program strategy

Sep 10, 2026

Blog

Greater empathy, greater efficiency: How patient-first clinical development benefits all of us

Sep 10, 2026

Blog

The future of patient recruitment: Building a more connected ecosystem

Sep 9, 2026

Case Study

Speed meets strategy: Delivering a critical FDA 1572 package in just seven days

Sep 9, 2026

Back

Access exclusive insights

Harness the power of clinical development with exclusive insights from our experts at Parexel

First Name *

Last Name *

Company *

Job Title *

Email *

Yes, I'd like to stay in touch. Please send me Parexel promotional insights and news.

Yes, I have read and acknowledge the Privacy Policy and Terms of Service *

Solutions

WHAT WE DO

HOW WE DO IT

Portfolio management and asset valuation

Early development and innovation

Integrated clinical development

Approval and access

Value substantiation lifecycle management

ParexelAI™

Flexible, scalable solutions.

Therapeutic Expertise

THERAPEUTIC EXPERTISE

CROSS-THERAPEUTIC EXPERTISE

General medicine

Infectious disease and vaccines

Immunology

Oncology

Neuroscience

Hematology

RELATED INSIGHTS

Insights

FEATURED INSIGHTS

NEW MEDICINES, NOVEL INSIGHTS

PODCAST

Cell & Gene Unscripted

Participate

INTERESTED IN PARTICIPATING?

TRIAL SITES

Patient volunteers

HEAR FROM REAL PATIENTS

About

Leadership team

Compliance, tax & privacy

Solutions

WHAT WE DO

HOW WE DO IT

Portfolio management and asset valuation

Early development and innovation

Integrated clinical development

Approval and access

Value substantiation lifecycle management

ParexelAI™

Flexible, scalable solutions.

Therapeutic Expertise

THERAPEUTIC EXPERTISE

CROSS-THERAPEUTIC EXPERTISE

General medicine

Infectious disease and vaccines

Immunology

Oncology

Neuroscience

Hematology

RELATED INSIGHTS

Insights

FEATURED INSIGHTS

NEW MEDICINES, NOVEL INSIGHTS

PODCAST

Cell & Gene Unscripted

Participate

INTERESTED IN PARTICIPATING?

TRIAL SITES

Patient volunteers

HEAR FROM REAL PATIENTS

About

Leadership team

Compliance, tax & privacy

From breakthrough science to real world impact — advancing cell and gene therapy, together

What you’ll learn

Access exclusive insights